View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Part 5 of an ongoing 12-part COVID-19 series, David Heymann, BA, MD, DTM&H, provides a brief update on the epidemiology of SARS-CoV-2 and evidence-based interventions for reducing transmission,. After the update, Professor Heymann answers critical clinician questions on COVID-19 transmission and mitigation.
Content based on an online CME program supported by an independent educational grant from Gilead Sciences.
Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Dr. Jens Lundgren discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19 from CCO
Jens D. Lundgren, MD, DMSc
Released: October 16, 2020
Barbara Rath, MD, PhD, HDR, discusses emerging COVID-19 data reported at the Virtual ECCVID 2020 Conference, in the CCO Infectious Disease podcast
Wong Chen Seong, MBBS, MRCP(UK), FAMS, provides a brief update on COVID-19 and answers clinician questions in the CCO Infectious Disease podcast
Wong Chen Seong, MBBS, MRCP(UK), FAMS
Released: October 16, 2020
Downloadable slides from CCO expert, Dr. Barbara Rath, summarizing new ECCVID data on COVID-19 transmission, pathogenesis, treatment, and prevention
Barbara Rath, MD, PhD, HDR
Released: October 9, 2020
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.